McKesson Corporation dba McKesson Drug Company: Drug Recall
Recall #D-0848-2022 · 04/21/2022
Class II: Risk
Recall Details
- Recall Number
- D-0848-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- McKesson Corporation dba McKesson Drug Company
- Status
- Ongoing
- Date Initiated
- 04/21/2022
- Location
- Memphis, TN, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 81,757 bottles
Reason for Recall
CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.
Product Description
Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL bottle, Rx only, Manufactured by: Teligent Pharma, Inc. Buena, NJ 08310 Distributed by: McKesson Corporation dba Sky Packaging 4071 Southridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-977-64
Distribution Pattern
Nationwide in the United States including Guam and the Northern Mariana Islands.
Other Recalls by McKesson Corporation dba McKesson Drug Company
- Class II: Risk 04/21/2022
- Class II: Risk 04/21/2022
- Class II: Risk 04/21/2022
- Class II: Risk 04/21/2022
- Class III: Low Risk 05/26/2021
View all recalls by McKesson Corporation dba McKesson Drug Company →
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.